Mapp remains involved in the production of the drug through its contracts with Kentucky BioProcessing, a subsidiary of Reynolds American.
Mapp Biopharmaceutical segue implicada na produción do fármaco a través dos seus contratos con Kentucky BioProcessing, unha compañía filial de Reynolds American.